Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.
Nicole D van HemertRik RozemeijerMichiel VoskuilMèra SteinPeter FrambachSaskia Z RittersmaAdriaan O KraaijeveldGeert E H LeendersPim van der HarstPierfrancesco AgostoniPieter R Stellanull nullPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)
Diabetics could potentially benefit from a dedicated stent, releasing sirolimus with a lipophilic carrier (amphilimus-formulation). Future trials should confirm the potential benefit of a PF-AES in this population.